{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:59:58Z","timestamp":1790020798744,"version":"4.0.1"},"reference-count":51,"publisher":"Japanese Society of Internal Medicine","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2010]]},"DOI":"10.2169\/internalmedicine.49.4211","type":"journal-article","created":{"date-parts":[[2010,12,15]],"date-time":"2010-12-15T06:06:17Z","timestamp":1292393177000},"page":"2659-2668","source":"Crossref","is-referenced-by-count":16,"title":["Influence of Low-Grade Inflammation on Plasma B-type Natriuretic Peptide Levels"],"prefix":"10.2169","volume":"49","author":[{"given":"Terumasa","family":"Inoue","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Kawai","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tokiko","family":"Nakane","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Nojiri","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kosuke","family":"Minai","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimiaki","family":"Komukai","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayuki","family":"Ogawa","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Hongo","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Matsushima","sequence":"additional","affiliation":[{"name":"Division of Clinical Epidemiology, Research Center for Medical Science, The Jikei University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiro","family":"Yoshimura","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Internal Medicine, The Jikei University School of Medicine"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"publisher","unstructured":"1. Kangawa K, Tawaragi Y, Oikawa S, et al. Identification of rat gamma atrial natriuretic polypeptide and characterization of the cDNA encoding its precursor. Nature 312: 152-155, 1984.","DOI":"10.1038\/310152a0"},{"key":"2","doi-asserted-by":"publisher","unstructured":"2. De Bold AJ. Arterial natriuretic factor: a hormone produced by the heart. Science 230: 767-770, 1985.","DOI":"10.1126\/science.2932797"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Sudoh T, Kangawa K, Minamino N, Matsuo H. A new natriuretic peptide in porcine brain. Nature 332: 78-81, 1988.","DOI":"10.1038\/332078a0"},{"key":"4","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1161\/01.CIR.0000057794.29667.08","volume":"107","year":"2003","unstructured":"4. Ito T, Yoshimura M, Nakamura S, et al. Inhibitory effect of natriuretic peptides on aldosterone synthase gene expression in cultured neonatal rat cardiocytes. Circulation 107: 807-810, 2003.","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Yasue H, Obata K, Okumura K, et al. Increased secretion of atrial natriuretic polypeptide from the left ventricle in patients with dilated cardiomyopathy. J Clin Invest 83: 46-51, 1989.","DOI":"10.1172\/JCI113883"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Saito Y, Nakao K, Arai H, et al. Augmented expression of atrial natriuretic polypeptide gene in ventricle of human failing heart. J Clin Invest 83: 298-305, 1998.","DOI":"10.1172\/JCI113872"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Mukoyama M, Nakao K, Hosoda K, et al. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide. J Clin Invest 87: 1402-1412, 1991.","DOI":"10.1172\/JCI115146"},{"key":"8","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1161\/01.CIR.90.1.195","volume":"90","year":"1994","unstructured":"8. Yasue H, Yoshimura M, Sumida H, et al. Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation 90: 195-203, 1994.","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"9","doi-asserted-by":"publisher","unstructured":"9. Yoshimura M, Yasue H, Okumura K, et al. Different secretion patterns of atrial natriuretic peptide and brain natriuretic peptide in patients with congestive heart failure. Circulation 87: 464-469, 1993.","DOI":"10.1161\/01.CIR.87.2.464"},{"key":"10","doi-asserted-by":"publisher","unstructured":"10. Morita E, Yasue H, Yoshimura M, et al. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction. Circulation 88: 82-91, 1993.","DOI":"10.1161\/01.CIR.88.1.82"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nakagawa O, Ogawa Y, Itoh H, et al. Rapid transcriptional activation and early mRNA turnover of brain natriuretic peptide in cardiocyte hypertrophy: Evidence for brain natriuretic peptide as an 'emergency' cardiac hormone against ventricular overload. J Clin Invest 96: 1280-1287, 1995.","DOI":"10.1172\/JCI118162"},{"key":"12","doi-asserted-by":"publisher","unstructured":"12. Tsutamoto T, Wada A, Maeda K, et al. Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure: prognostic role of plasma brain natriuretic peptide concentration in patients with chronic symptomatic left ventricular dysfunction. Circulation 96: 509-516, 1997.","DOI":"10.1161\/01.CIR.96.2.509"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Boerrigter G, Costello-Boerrigter LC, Burnett JC Jr. Natriuretic peptides in the diagnosis and management of chronic heart failure. Heart Fail Clin 5: 501-514, 2009.","DOI":"10.1016\/j.hfc.2009.04.002"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Shapiro BP, Chen HH, Burnett JC Jr, Redfield MM. Use of plasma brain natriuretic peptide concentration to aid in the diagnosis of heart failure. Mayo Clin Proc 78: 481-486, 2003.","DOI":"10.4065\/78.4.481"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15. Mizuno Y, Yoshimura M, Harada E, et al. Plasma levels of A- and B-type natriuretic peptides in patients with hypertrophic cardiomyopathy or idiopathic dilated cardiomyopathy. Am J Cardiol 86: 1036-1040, 2000.","DOI":"10.1016\/S0002-9149(00)01147-4"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Harada M, Itoh H, Nakagawa O, et al. Significance of ventricular myocytes and nonmyocytes interaction during cardiocyte hypertrophy: Evidence for endothelin-1 as a paracrine hypertrophic factor from cardiac nonmyocytes. Circulation 96: 3737-3744, 1997.","DOI":"10.1161\/01.CIR.96.10.3737"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Kuwahara K, Saito Y, Harada M, et al. Involvement of cardiotrophin-1 in cardiac myocyte-nonmyocyte interactions during hypertrophy of rat cardiac myocyte in vitro. Circulation 100: 1116-1124, 1999.","DOI":"10.1161\/01.CIR.100.10.1116"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Harada M, Itoh H, Nakagawa O, et al. Effect of interleukin-lB on cardiac hypertrophy and production of natriuretic peptides in rat cardiocyte culture. J Mol Cell Cardiol 31: 1997-2006, 1999.","DOI":"10.1006\/jmcc.1999.1030"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Members of the American College of Chest Physicians\/Society of Critical Care Medicine Consensus Conference Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20: 864-874, 1992.","DOI":"10.1097\/00003246-199206000-00025"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Blake GJ, Ridker PM. Inflammatory bio-markers and cardiovascular risk prediction. J Intern Med 252: 283-294, 2002.","DOI":"10.1046\/j.1365-2796.2002.01019.x"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. New Eng J Med 350: 1387-1397, 2004.","DOI":"10.1056\/NEJMoa032804"},{"key":"22","doi-asserted-by":"publisher","unstructured":"22. Labarrere CA, Lee JB, Nelson DR, Al-Hassani M, Miller SJ, Pitts DE. C-reactive protein, arterial endothelial activation, and development of transplant coronary artery disease: a prospective study. Lancet 360: 1462-1467, 2002.","DOI":"10.1016\/S0140-6736(02)11473-5"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Zacho J, Tybjaerg-Hansen A, Jensen JS, Grande P, Sillesen H, Nordestgaard BG. Genetically elevated C-reactive protein and ischemic vascular disease. New Engl J Med 359: 1897-1908, 2008.","DOI":"10.1056\/NEJMoa0707402"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Pai JK, Pischon T, Ma J, et al. Inflammatory markers and the risk of coronary heart disease in men and women. New Engl J Med 351: 2599-2610, 2004.","DOI":"10.1056\/NEJMoa040967"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25. Ridker PM, Rifai N, Rose L, Buring JE, Cook NR. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. New Engl J Med 347: 1557-1565, 2002.","DOI":"10.1056\/NEJMoa021993"},{"key":"26","doi-asserted-by":"publisher","unstructured":"26. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 285: 2481-2485, 2001.","DOI":"10.1001\/jama.285.19.2481"},{"key":"27","doi-asserted-by":"publisher","unstructured":"27. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation 105: 1135-1143, 2002.","DOI":"10.1161\/hc0902.104353"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Ridker PM, Cannon CP, Morrow D, et al. C-reactive protein levels and outcomes after statin therapy. New Engl J Med 352: 20-28, 2005.","DOI":"10.1056\/NEJMoa042378"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Suzuki S, Yoshimura M, Nakayama M, et al. Plasma level of B-type natriuretic peptide as a prognostic marker after acute myocardial infarction: a long-term follow-up analysis. Circulation 110: 1387-1391, 2004.","DOI":"10.1161\/01.CIR.0000141295.60857.30"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Wang TJ, Larson MG, Levy D, et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350: 655-663, 2004.","DOI":"10.1056\/NEJMoa031994"},{"key":"31","doi-asserted-by":"publisher","unstructured":"31. Anand IS, Fisher LD, Chiang YT, et al. For the Val-HeFT Investigators. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT). Circulation 107: 1278-1283, 2003.","DOI":"10.1161\/01.CIR.0000054164.99881.00"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Berger R, Huelsman M, Strecker K, et al. B-type natriuretic peptide predicts sudden death in patients with chronic heart failure. Circulation 105: 2392-2397, 2002.","DOI":"10.1161\/01.CIR.0000016642.15031.34"},{"key":"33","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1161\/01.CIR.93.11.1963","volume":"93","year":"1996","unstructured":"33. Omland T, Aakvaag A, Bonarjee VV, et al. Plasma brain natriuretic peptide as an indicator of left ventricular systolic function and long-term survival after acute myocardial infarction: comparison with plasma atrial natriuretic peptide and N-terminal proatrial natriuretic peptide. Circulation 93: 1963-1969, 1996.","journal-title":"Circulation","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7322","issn-type":"print"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Richards AM, Nicholls MG, Espiner EA, et al. B-type natriuretic peptides and ejection fraction for prognosis after myocardial infarction. Circulation 107: 2786-2792, 2003.","DOI":"10.1161\/01.CIR.0000070953.76250.B9"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Scott PA, Barry J, Roberts PR, Morgan JM. Brain natriuretic peptide for the prediction of sudden cardiac death and ventricular arrhythmias: a meta-analysis. Eur J Heart Fail 11: 958-966, 2009.","DOI":"10.1093\/eurjhf\/hfp123"},{"key":"36","doi-asserted-by":"publisher","unstructured":"36. Di Angelantonio E, Chowdhury R, Sarwar N, et al. B-type natriuretic peptides and cardiovascular risk: systematic review and meta-analysis of 40 prospective studies. Circulation 120: 2177-2187, 2009.","DOI":"10.1161\/CIRCULATIONAHA.109.884866"},{"key":"37","doi-asserted-by":"publisher","unstructured":"37. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 55: 613-618, 1977.","DOI":"10.1161\/01.CIR.55.4.613"},{"key":"38","first-page":"303","volume":"5","year":"1989","unstructured":"38. Du Bois D, Du Bois EF. A formula to estimate the approximate surface area if height and weight be known. 1916. Nutrition 5: 303-311, 1989.","journal-title":"Nutrition","ISSN":"https:\/\/id.crossref.org\/issn\/0899-9007","issn-type":"print"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, for the Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med 130: 461-470, 1999.","DOI":"10.7326\/0003-4819-130-6-199903160-00002"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Matsuo S, Imai E, Horio M, et al. Collaborators developing the Japanese equation for estimated GFR. Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53: 982-992, 2009.","DOI":"10.1053\/j.ajkd.2008.12.034"},{"key":"41","doi-asserted-by":"publisher","unstructured":"41. Bankers-Fulbright JL, Kalli KR, NcKean DJ. Interleukin-1 signal transduction. Life Sciences 59: 61-83, 1996.","DOI":"10.1016\/0024-3205(96)00135-X"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Barnes PJ, Karin M. Nuclear factor kappa B: Nuclear factor-kappa B: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336: 1066-1071, 1997.","DOI":"10.1056\/NEJM199704103361506"},{"key":"43","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1161\/01.HYP.33.1.283","volume":"33","year":"1999","unstructured":"43. He Q, Lapointe MC. Interleukin-1 beta regulation of the human brain natriuretic peptide promoter involves Ras-, Rac-, and p38 kinase-dependent pathways in cardiac myocytes. Hypertension 33: 283-289, 1999.","journal-title":"Hypertension","ISSN":"https:\/\/id.crossref.org\/issn\/0194-911X","issn-type":"print"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Kuwahara K, Saito Y, Harada M, et al. Involvement of cardiotrophin-1 in cardiac myocyte-nonmyocyte interactions during hypertrophy of rat cardiac myocytes in vitro. Circulation 100: 1116-1124, 1999.","DOI":"10.1161\/01.CIR.100.10.1116"},{"key":"45","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/res.89.3.198","volume":"89","year":"2001","unstructured":"45. Hare JM. Oxidative stress and apoptosis in heart failure progression. Circulation Research 89: 198-200, 2001.","journal-title":"Circulation Research","ISSN":"https:\/\/id.crossref.org\/issn\/0009-7330","issn-type":"print"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Kojima M, Minamino N, Kangawa K, Matsuo H. Cloning and sequence analysis of cDNA encoding a precursor for rat brain natriuretic peptide. Biochem Biophys Res Commun 159: 1420-1426, 1989.","DOI":"10.1016\/0006-291X(89)92268-7"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Kushner I. The phenomenon of the acute phase response. Ann N Y Acad Sci 389: 39-48, 1982.","DOI":"10.1111\/j.1749-6632.1982.tb22124.x"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Lei K-J, Liu T, Zon G, Soravia E, Liu T-Y, Goldman ND. Genomic DNA sequence for human C-reactive protein. J Biol Chem 260: 13377-13383, 1985.","DOI":"10.1016\/S0021-9258(17)38880-4"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Usuku H, Nakayama M, Sumida H, et al. Pump failure death and sudden cardiac death in patients with cardiac dysfunction: A search for prognostic predictive factors-A long-term follow-up study. J Cardiol 55: 55-64, 2010.","DOI":"10.1016\/j.jjcc.2009.08.005"},{"key":"50","doi-asserted-by":"publisher","unstructured":"50. Saito Y, Nakao K, Nishimura K, et al. Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function. Circulation 76: 115-124, 1987.","DOI":"10.1161\/01.CIR.76.1.115"},{"key":"51","doi-asserted-by":"publisher","unstructured":"51. Yoshimura M, Yasue H, Morita E, et al. Hemodynamic, renal, and hormonal responses to brain natriuretic peptide infusion in patients with congestive heart failure. Circulation 84: 1581-1588, 1991.","DOI":"10.1161\/01.CIR.84.4.1581"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/49\/24\/49_24_2659\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,15]],"date-time":"2021-11-15T13:54:51Z","timestamp":1636984491000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/49\/24\/49_24_2659\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":51,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.49.4211","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010]]}}}